Noubar Afeyan insider trades
Open-market stock purchases and sales by Noubar Afeyan, Unknown at Moderna, Inc, from SEC Form 4 filings since Sep 27, 2010.
Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging +52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 21, 2026 | MRNA Moderna, Inc | Sold | $434K |
| May 21, 2026 | MRNA Moderna, Inc | Bought (not open market) | — |
| May 6, 2026 | MRNA Moderna, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought | $25M |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought | $25M |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
| Mar 2, 2026 | GENB Generate Biomedicines, Inc | Bought (not open market) | — |
Companies traded
- MRNA Moderna, Inc: 312 sales, last May 21, 2026
- GENB Generate Biomedicines, Inc: 2 buys, last Mar 2, 2026
- OMGA Omega Therapeutics, Inc: other filings, last Jun 7, 2023
- RUBY Rubius Therapeutics, Inc: other filings, last May 12, 2022
- MCRB Seres Therapeutics, Inc: 1 buy, 3 sales, last Jun 18, 2019
- EVLO Evelo Biosciences, Inc: other filings, last Jun 12, 2019
- BGMD BG Medicine, Inc: 19 buys, 23 sales, last Dec 9, 2015
- EBIO Eleven Biotherapeutics, Inc: other filings, last Mar 20, 2014
- BIND BIND Therapeutics, Inc: 1 buy, last Sep 25, 2013